Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Health
Biotech
First Opinion
The Readout

FDA’s new paradigm & Trump’s budget bluster

  • Damian Garde
  • Meghana Keshavan

By Damian Garde and Meghana Keshavan May 19, 2017

Reprints
The READOUT
Alex Hogan/STAT

The Readout for May 19, 2017

About the Authors Reprints

Damian Garde

Damian Garde

National Biotech Reporter

Damian Garde covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast.

Meghana Keshavan

Meghana Keshavan

Biotech Correspondent

Meghana Keshavan covers biotech and contributes to The Readout newsletter.

New weight loss drugs are changing the narrative on…
New weight loss drugs are changing the narrative on obesity, with a push from pharma
The X-waiver for buprenorphine prescribing is gone. It’s time…
The X-waiver for buprenorphine prescribing is gone. It’s time to spread the word
Researching collagen to help his achy knees, a statistician…
Researching collagen to help his achy knees, a statistician explores the painfully weak evidence
Regeneron targets obesity, a new microbiome deal, & comparing…
Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries…
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue
Docs disagree with FDA on Aduhelm, Swiss giants pinch…
Docs disagree with FDA on Aduhelm, Swiss giants pinch pennies, & one SPAC makes it rain

Recommended Stories